Adverse drug reactions induced by traditional Chinese medicine treatment for new coronavirus pneumonia during the medical observation period
10.12206/j.issn.1006-0111.202005040
- VernacularTitle:新型冠状病毒肺炎医学观察期中医治疗方案的不良反应分析
- Author:
Ying LI
1
;
Fangyuan XIE
1
;
Jing ZHANG
1
;
Lijuan LIANG
1
;
Yunying HU
1
;
Guoqing ZHANG
1
Author Information
1. Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200438, China.
- Keywords:
COVID-19;
medical observation period;
TCM;
ADR
- From:
Journal of Pharmaceutical Practice
2020;38(5):404-408
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the characteristics of the adverse drug reaction (ADR) in the traditional Chinese medicine (TCM) treatment followed the "COVID-19 Diagnosis and Treatment Program (trial version 7)" during the medical observation period, and to provide a guideline for rational clinical drug use. Methods 9 TCM induced ADR were collected from CNKI, Wanfang database and PubMed. Statistical analysis was conducted on gender, age, occurrence time, involved system/organ, treatment, outcome and relevance evaluation. Results 61 literatures were collected according to the inclusion and exclusion criteria with 70 cases and 5 TCM prescriptions. There was no significant bias in gender. The age span was large. Most ADR occurred within 1 day after administration. The involved systems/organs are extensive, mainly on the skin and its accessories. The most common therapeutic drugs were antihistamines and steroids, and other medications are mainly for symptom treatment. The turnaround time was 1 h in most cases (47%). Conclusions During the observation period, the incident population was widely distributed and there was no obvious characteristics. Medication monitoring should be reinforced to reduce the ADR incidence.
